Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An announcement from EBOS Group Limited ( (AU:EBO) ) is now available.
EBOS Group Limited held its annual shareholder meeting where four resolutions were passed, including the election and re-election of directors Coline McConville, Stuart McLauchlan, and Mark Bloom, as well as the authorization for directors to set Deloitte’s auditor fees. This meeting underscores the company’s commitment to maintaining strong governance and operational oversight, which could positively impact its market position and stakeholder confidence.
The most recent analyst rating on (AU:EBO) stock is a Hold with a A$28.00 price target. To see the full list of analyst forecasts on EBOS Group Limited stock, see the AU:EBO Stock Forecast page.
More about EBOS Group Limited
EBOS Group Limited operates in the healthcare and animal care industries, providing a range of products and services across Australasia. The company focuses on the distribution of healthcare, medical, and pharmaceutical products, as well as animal care products, serving a diverse market that includes hospitals, pharmacies, and veterinary clinics.
Average Trading Volume: 138,557
Technical Sentiment Signal: Sell
Current Market Cap: A$5.13B
For a thorough assessment of EBO stock, go to TipRanks’ Stock Analysis page.